Division of Cardiology, Medical University of Vienna, Vienna, Austria.
Division of Cardiovascular and Interventional Radiology, Medical University of Vienna, Vienna, Austria.
Obesity (Silver Spring). 2024 Sep;32(9):1670-1679. doi: 10.1002/oby.24105.
Epicardial adipose tissue (EAT) quantity is associated with poor cardiovascular outcomes. However, the quality of EAT may be of incremental prognostic value. Cardiac magnetic resonance (CMR) is the gold standard for tissue characterization but has never been applied for EAT quality assessment. We aimed to investigate EAT quality measured on CMR T1 mapping as a predictor of poor outcomes in an all-comer cohort.
We investigated the association of EAT area and EAT T1 times (EAT-T1) with a composite endpoint of nonfatal myocardial infarction, heart failure hospitalization, and all-cause death.
A total of 966 participants were included (47.2% female; mean age: 58.4 years) in this prospective observational CMR registry. Mean EAT area and EAT-T1 were 7.3 cm and 268 ms, respectively. On linear regression, EAT-T1 was not associated with markers of obesity, dyslipidemia, or comorbidities such as diabetes (p > 0.05 for all). During a follow-up of 57.7 months, a total of 280 (29.0%) events occurred. EAT-T1 was independently associated (adjusted hazard ratio per SD: 1.202; 95% CI: 1.022-1.413; p = 0.026) with the composite endpoint when adjusted for established clinical risk.
EAT quality (as assessed via CMR T1 times), but not EAT quantity, is independently associated with a composite endpoint of nonfatal myocardial infarction, heart failure hospitalization, and all-cause death.
心外膜脂肪组织(EAT)的数量与不良心血管结局相关。然而,EAT 的质量可能具有额外的预后价值。心脏磁共振(CMR)是组织特征的金标准,但从未应用于 EAT 质量评估。我们旨在研究 CMR T1 映射测量的 EAT 质量作为全因队列中不良结局的预测因子。
我们研究了 EAT 面积和 EAT T1 时间(EAT-T1)与非致死性心肌梗死、心力衰竭住院和全因死亡的复合终点之间的关联。
这项前瞻性观察性 CMR 注册研究共纳入 966 名参与者(47.2%为女性;平均年龄:58.4 岁)。EAT 面积和 EAT-T1 的平均值分别为 7.3cm 和 268ms。在线性回归中,EAT-T1 与肥胖、血脂异常或糖尿病等合并症的标志物无相关性(所有 p>0.05)。在 57.7 个月的随访中,共发生 280 例(29.0%)事件。EAT-T1 与复合终点独立相关(调整后的每标准差危险比:1.202;95%置信区间:1.022-1.413;p=0.026),调整了既定的临床风险。
EAT 质量(通过 CMR T1 时间评估),而不是 EAT 量,与非致死性心肌梗死、心力衰竭住院和全因死亡的复合终点独立相关。